SomnoMed Limited
SOMNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $135,233 | $34,431 | $75,201 | $102,320 |
| - Cash | $17,293 | $16,179 | $11,956 | $15,644 |
| + Debt | $8,026 | $6,720 | $23,511 | $12,010 |
| Enterprise Value | $125,965 | $24,972 | $86,756 | $98,686 |
| Revenue | $111,493 | $91,651 | $83,616 | $72,580 |
| % Growth | 21.6% | 9.6% | 15.2% | – |
| Gross Profit | $66,729 | $55,131 | $45,769 | $39,152 |
| % Margin | 59.9% | 60.2% | 54.7% | 53.9% |
| EBITDA | $1,583 | -$2,329 | -$3,117 | -$1,983 |
| % Margin | 1.4% | -2.5% | -3.7% | -2.7% |
| Net Income | -$3,456 | -$12,242 | -$7,999 | -$4,437 |
| % Margin | -3.1% | -13.4% | -9.6% | -6.1% |
| EPS Diluted | -0.016 | -0.1 | -0.097 | -0.054 |
| % Growth | 83.7% | -2.7% | -80.4% | – |
| Operating Cash Flow | $7,784 | -$6,333 | -$3,880 | $1,858 |
| Capital Expenditures | -$2,421 | -$1,387 | -$6,415 | -$8,788 |
| Free Cash Flow | $5,363 | -$7,720 | -$10,295 | -$6,931 |